Mr Matthew Carter > Dechert LLP > Washington DC, United States > Lawyer Profile
Dechert LLP Offices
1900 K STREET, NW
WASHINGTON DC 20006
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Mr Matthew Carter
Work Department
Corporate
Position
Partner
Career
Matthew J. Carter focuses his practice on corporate and securities matters, with a particular emphasis on representing issuers and investment banks in public and private securities transactions. Mr. Carter has significant experience advising permanent capital vehicles such as business development companies and closed-end funds. In addition, Mr. Carter advises clients on the formation and structuring of investment advisers and private funds. He also represents private equity and strategic buyers and sellers in corporate transactions and advises clients on corporate governance and other general corporate matters.
Prior to joining Dechert, Mr. Carter served as legislative counsel to a member of the United States House of Representatives.
Education
- Vanderbilt University, B.E., 2003, cum laude
- Vanderbilt University Law School, J.D., 2010, Law and Business Certificate, Recipient of the Vanderbilt Scholastic Excellence Award: Mergers and Acquisitions Deal Dynamics
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation